NovaBridge Biosciences: current_liabilities
| Value | {"amount": 88295000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/473ed3c2-9cf7-467c-bc2b-bd8e92c57ebb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-135440Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/current-liabilities/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/473ed3c2-9cf7-467c-bc2b-bd8e92c57ebb
History
- supersedes {"unit": "CNY", "value": 576125000, "concept": "us-gaap:LiabilitiesCurrent"} (evidence 0001193125-21-135440)